Compare IZEA & BTMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IZEA | BTMD |
|---|---|---|
| Founded | 2006 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Advertising | Medicinal Chemicals and Botanical Products |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 74.9M | 64.4M |
| IPO Year | 2010 | 2021 |
| Metric | IZEA | BTMD |
|---|---|---|
| Price | $4.26 | $2.27 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $2.83 |
| AVG Volume (30 Days) | 50.9K | ★ 280.5K |
| Earning Date | 05-14-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 100.00 | ★ 722.22 |
| EPS | N/A | ★ 0.74 |
| Revenue | $20,099,695.00 | ★ $192,219,000.00 |
| Revenue This Year | $20.81 | $2.03 |
| Revenue Next Year | $14.86 | $6.58 |
| P/E Ratio | $54.43 | ★ $3.08 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.79 | $1.27 |
| 52 Week High | $5.86 | $4.75 |
| Indicator | IZEA | BTMD |
|---|---|---|
| Relative Strength Index (RSI) | 62.26 | 71.36 |
| Support Level | $4.31 | $2.02 |
| Resistance Level | $4.65 | $2.37 |
| Average True Range (ATR) | 0.19 | 0.12 |
| MACD | 0.01 | 0.05 |
| Stochastic Oscillator | 74.74 | 92.05 |
IZEA Worldwide Inc offers solutions that range from creator agency services to creator technologies to a marketplace that connects marketers with creators. The Company provides value through managing custom content workflow, creator search and targeting, bidding, analytics, and payment processing. The company also enables creators to monetize their content, creativity, and influence through brands and marketers. The company compensates these creators for producing content, such as long and short-form text, videos, photos, status updates, and illustrations, for marketers or distributing such content on behalf of marketers through their websites, blogs, and social media channels.
Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The company derives revenue from United States and also has its presence in other countries.